Clopidogrel Clinical Trial
Official title:
PACT (Platelet Activity After Clopidogrel Termination)
Clopidogrel is a medication that is used to decrease the ability of platelets to form blood
clots.
The theory has been proposed that, in patients with coronary artery disease or stroke,
increased platelet function after discontinuation of clopidogrel therapy is associated with
an increased clotting risk. However, this theory has never been rigorously tested.
The goal of this research is to determine whether discontinuation of clopidogrel results in
increased platelet function.
In this study, we will address the question: does discontinuation of clopidogrel result in platelet hyperreactivity? We will perform a double-blind, placebo-controlled, crossover study in normal subjects, in whom platelet reactivity will be measured before clopidogrel or placebo, during clopidogrel or placebo, and at various time points after discontinuation of clopidogrel or placebo. The dose of clopidogrel will be the standard, FDA-approved dose: 75 mg daily. All subjects will be treated with aspirin 81 mg daily throughout the 57 days of study assessment in both the clopidogrel arm and the placebo arm, because the clinically relevant question is: in patients who remain on aspirin, does discontinuation of clopidogrel result in platelet hyperreactivity? ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03613337 -
Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
|
||
Completed |
NCT01582217 -
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
|
N/A | |
Completed |
NCT02484924 -
The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
|
||
Completed |
NCT01960296 -
Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?
|
Phase 2 | |
Completed |
NCT04431349 -
Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
|
||
Completed |
NCT00753753 -
VerifyNow French Registry
|
N/A | |
Completed |
NCT05512546 -
The Prevention of Thromboembolic Complications Associated With Coil Embolization
|
||
Completed |
NCT01231867 -
Cohort Study of Clopidogrel and Proton Pump Inhibitors
|
N/A | |
Withdrawn |
NCT00363753 -
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
|
Phase 1 |